Literature DB >> 29219792

[Unilateral blindness following a non-surgical rhinoplasty with filler].

L W Schelke1, M Fick, L J van Rijn, T Decates, P J Velthuis, F Niessen.   

Abstract

BACKGROUND: A rare but known adverse event following a cosmetic filler treatment is unilateral blindness. In the Netherlands, this complication has not been reported in a patient before. CASE DESCRIPTION: A 26-year-old woman developed unilateral blindness after undergoing a cosmetic treatment of the dorsum nasi in which hyaluronic acid was used as filler. The blindness was caused by backflow of the filler via the ophthalmic artery into the carotid internal artery.
CONCLUSION: There is no proven effective treatment for this adverse event. Therefore prevention is of great importance. This requires knowledge of the anatomy of the facial blood vessels and a well-developed injection technique.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29219792

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  Non-Surgical Rhinoplasty: The Ascending Technique and a 14-Year Retrospective Study of 2130 Cases.

Authors:  Ramtin Kassir; Aniketh Venkataram; Azyta Malek; Deeksha Rao
Journal:  Aesthetic Plast Surg       Date:  2020-11-20       Impact factor: 2.326

Review 2.  Patient Satisfaction After Non-surgical Rhinoplasty Using Hyaluronic Acid: A Literature Review.

Authors:  Thomas Radulesco; Guillaume De Bonnecaze; Martin Penicaud; Patrick Dessi; Justin Michel
Journal:  Aesthetic Plast Surg       Date:  2021-03-03       Impact factor: 2.326

3.  Evaluation of Adverse Effects of Resorbable Hyaluronic Acid Fillers: Determination of Macrophage Responses.

Authors:  Wim H De Jong; Danyel Jennen; Peter H J Keizers; Hennie M Hodemaekers; Jolanda P Vermeulen; Frank Bakker; Paul Schwillens; Marcel van Herwijnen; Marlon Jetten; Jos C S Kleinjans; Robert E Geertsma; Rob J Vandebriel
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.